ERS Genomics Licenses CRISPR/Cas9 Genome Editing Patents to Evotec – Business Wire (press release)
Business Wire (press release) |
ERS Genomics Licenses CRISPR/Cas9 Genome Editing Patents to Evotec
Business Wire (press release) “This license enables them to further expand their service offering in the CRISPR gene-editing space.” Evotec uses the CRISPR/Cas9 technology to drive its target identification platform as well as aid in the validation and unmasking of targets derived … Evotec Adds Licence From ERS Genomics To CRISPR Service Offering – Quick Facts Evotec Expands CRISPR-Based Technology Offering with Licence from ERS Genomics |
